Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Jun;178(6):1131-7.
doi: 10.1016/s0002-9378(98)70313-8.

Adenocarcinoma of the uterine cervix metastatic to lymph nodes

D E Cohn  1 , W A Peters 3rd, H G Muntz, R Wu, B E Greer, H K Tamimi, C W Drescher, M R Smith, J L Yon, R Schmidt, B A Goff
Affiliations

Adenocarcinoma of the uterine cervix metastatic to lymph nodes

D E Cohn et al. Am J Obstet Gynecol. 1998 Jun.

Abstract

Objective: We set out to evaluate the prognostic factors in cervical adenocarcinoma metastatic to lymph nodes.

Study design: We performed a retrospective review of 40 patients with cervical adenocarcinoma and lymph node metastasis from 1976 to 1996.

Results: Thirty-four patients had adenocarcinoma, and six had adenosquamous carcinoma. Median survival was 50 months. The median survival for patients with stage I disease was 69 months. Stage at diagnosis, treatment with radical hysterectomy, and receiving adjuvant therapy were associated with prolonged survival. A trend toward improved survival was noted with the use of concurrent radiation and chemotherapy as an adjuvant therapy.

Conclusions: Adenocarcinoma metastatic to the lymph nodes does not have a uniformly poor prognosis, especially with early-stage disease. Improved survival was observed with the use of adjuvant therapy, specifically the use of combined chemotherapy and radiation after radical hysterectomy. The optimal therapy in this setting is yet to be determined.

PubMed Disclaimer

Publication types

MeSH terms